Clinical trial country use share
RecordSTO-01M2KJ7XCG-3Y4BJ2059J-BJMGCS
China · 2023
Clinical trial country use share in China was 15% in 2023 (IQVIA).
Clinical trial locations by country in China: every year, the rank and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Key findings:
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
Country utilization by region has shifted significantly in the past five years with Western Europe share declining by 21% (from 32% to 25% of global total) and Eastern Europe share decreasing 33% (from 17% to 11%), as North America share increased 17% (from 19% to 23%) and China share increased 57% (from 10% to 15%).
Checked: the figure 15%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2023). Rethinking Clinical Trial Country Prioritization. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCS
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Rethinking Clinical Trial Country Prioritization." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCS.
- Chicago
- IQVIA Institute. "Rethinking Clinical Trial Country Prioritization." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCS.
- BibTeX
- @misc{iqvia2023clinicalbjmgcs, author = {{IQVIA Institute}}, title = {Rethinking Clinical Trial Country Prioritization}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCS}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Rethinking Clinical Trial Country Prioritization
- Type
- Press release
- Published
- —
- Locator
- Key findings:
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Permanent URL
- /stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCS